Why healthcare can’t innovate like Silicon Valley | The Dip Podcast

Massively Better Healthcare: A Deep Dive into US Healthcare Innovation

Key Concepts:

• Quadruple Aim: Lowering cost, increasing access, improving outcomes, and improving the patient/provider experience.
• Medical Loss Ratio (MLR): The percentage of premium dollars an insurer spends on medical care and quality improvement, as opposed to administrative costs.
• Value-Based Care: A healthcare delivery model that rewards providers for patient health outcomes rather than the volume of services provided.
• Job Lock: The reluctance to change jobs due to the loss of health insurance benefits.
• Aligning Margin and Mission: Ensuring a business’s profit motive is directly tied to improving healthcare outcomes.
• The “Icky Zone”: Companies whose profits are derived from worsening healthcare outcomes (e.g., exploiting addiction).
• Portable Insurance: Health insurance that is not tied to employment and can be carried from job to job.
• Dual Eligibles: Individuals eligible for both Medicare and Medicaid, often representing vulnerable populations.

I. The State of US Healthcare & The Need for Innovation

The US healthcare system, despite significant investment in research and development, is characterized by high costs, complex processes, and unequal access to quality care. While the US excels at medical advancements, these benefits are not universally distributed, leading to disparities in life expectancy based on socioeconomic status, race, and location. The system is riddled with intermediaries (PBMs, wholesalers) that contribute to inflated prices, often to the detriment of patients. Hi Teo, author of Massively Better Healthcare, argues that the system isn’t intentionally designed for clarity or efficiency, and innovators shouldn’t wait to fully understand it before attempting to improve it. A key issue is the misalignment of incentives, where insurers, capped at a 15% profit margin by the Affordable Care Act (ACA), are incentivized to grow revenue by increasing costs rather than controlling them, leading to vertical integration (buying pharmacies, PBMs, and providers).

II. Defining “Massively Better” Healthcare

Teo defines “massively better” healthcare, initially considered as “100x better,” as achieving the quadruple aim: lowering costs, increasing access, improving outcomes, and enhancing the experience for both patients and providers. This isn’t about incremental improvements but substantial, transformative change. She illustrates the system’s complexity with a personal anecdote: obtaining a prescription for eczema revealed that paying out-of-pocket could be cheaper than using insurance, highlighting the opaque and often illogical pricing structures. This experience is common, demonstrating the need for simplification and transparency.

III. The US Healthcare “Food Chain” & Power Dynamics

The US healthcare system comprises several key stakeholders:

• Providers: Doctors, hospitals, and other healthcare professionals delivering care.
• Payers: Insurance companies (private and public – Medicare, Medicaid, VA) financing care. Employer-sponsored insurance is a unique feature of the US system.
• Pharma: Pharmaceutical companies and the associated supply chain.
• Patients: Individuals receiving care, arguably the most important stakeholder.

Power is concentrated among payers and pharma, creating barriers to innovation that prioritizes patient well-being and affordability. The current system often prioritizes treating illness rather than preventing it.

IV. Innovation in Healthcare: Who & How?

Innovation isn’t limited to startups; it can also occur within established organizations. Teo emphasizes the importance of aligning “margin and mission” – ensuring that a business’s profitability is directly linked to improving healthcare. She warns against entering the “icky zone,” exemplified by companies like Juul, which prioritized profit over public health.

The process of innovation is complicated by the unique characteristics of the healthcare industry. Unlike other sectors, healthcare requires a “slow to go fast” approach due to regulatory hurdles and the high stakes involved.

V. The Role of Regulation & Transparency

While some regulation is needed to promote healthy competition and openness, outdated legislation can hinder innovation. A key issue is the annual enrollment cycle for health insurance, which incentivizes payers to focus on short-term gains rather than long-term preventative care. The lack of transparency in pricing and outcomes makes it difficult for patients to make informed decisions, rendering “choice” illusory. The ACA’s requirement for insurers to publish prices is a step in the right direction, but outcome data remains largely inaccessible.

VI. Emerging Technologies & Future Prospects

Wearable technology, biomarkers, and digital health tools offer potential for proactive and personalized healthcare. While initially expensive, these technologies are expected to become more accessible as economies of scale are achieved. These tools empower patients to manage their health, but safeguards are needed to ensure their effectiveness and prevent misinformation.

The demographic shift towards an aging population creates both a challenge and an opportunity for innovation. Medicare Advantage plans, with their value-based care models, can facilitate investment in preventative care and address social determinants of health (e.g., transportation, medication management).

VII. Addressing Disparities & Equitable Innovation

While some innovators initially target affluent patients, there’s growing momentum towards developing solutions for underserved populations. Technology can act as an equalizer, but it’s crucial to bake inclusivity into the design process and measure the impact on all demographics.

VIII. The Future of Insurance & Systemic Change

Teo proposes a significant systemic change: implementing portable health insurance plans that extend beyond the annual enrollment cycle. This would incentivize payers to invest in long-term health and preventative care. She also highlights the issue of “job lock,” where individuals are reluctant to change jobs due to fear of losing health insurance, and argues that portable insurance could promote labor market flexibility.

Notable Quotes:

• “Choice without transparency is not choice at all.” – Hi Teo
• “Aligning the margin and the mission… ensuring that the business models that you're creating are aligned so that you're only profiting when healthcare is improving.” – Hi Teo
• “You have to go slow to go fast in healthcare.” – Hi Teo

Conclusion:

The US healthcare system is ripe for disruption, but innovation requires a nuanced understanding of its complexities and a commitment to aligning profit with patient well-being. Addressing systemic issues like misaligned incentives, lack of transparency, and the limitations of annual enrollment is crucial. Emerging technologies offer promising solutions, but equitable access and a focus on preventative care are essential to achieving “massively better” healthcare for all Americans. The future of healthcare hinges on a shift towards value-based care, portable insurance, and a renewed focus on the quadruple aim.